Table 1.
Summary of baseline data.
| Characteristic | Patients (n=903) |
|---|---|
| Mean age (years) | 59.4±14.3 |
| Male | 482 (53.4%) |
| Female | 421 (46.6%) |
| BMI (Kg/m2) | 1.79±0.18 |
| Heart failure | 678 (75.1%) |
| NYHA class | |
| I | 60 (6.6%) |
| II | 284 (31.4%) |
| III | 296 (32.7%) |
| IV | 38 (4.2%) |
| EuroSCORE II | 3.39±5.01 (0.5 - 58.6) |
| LVEF | 60.6±12.0 (16 - 91) |
| Coronary artery disease | |
| Angina class IV | 23 (2.5%) |
| Previous AMI | 36 (4.0%) |
| Comorbid conditions | |
| Hypertension | 551 (61.0%) |
| Renal impairment | 56 (6.2%) |
| Renal replacement therapy | 18 (2.0%) |
| Cerebrovascular disease | 57 (6.3%) |
| COPD (moderated or severe) | 49 (5.4%) |
| Active smoking | 83 (9.2%) |
| Diabetes mellitus | 163 (18.1%) |
| Cancer | 24 (2.7%) |
| Endocarditis | 74 (8.3%) |
| Antiplatelet therapy | 66 (7.3%) |
| Assisted ventilation | 17 (2.0%) |
| Use of the inotropic drug | 183 (20.4%) |
| Intra-aortic balloon pump | 2 (0.3%) |
| Pulmonary artery systolic pressure | 43.6±17.0 (9 - 117) |
| Rhythm on ECG | |
| Sinus rhythm | 771 (85.4%) |
| Arrhythmia | 132 (14.6%) |
| Pacing | 34 (3.7%) |
| Other | |
| PCI | 29 (3.2%) |
| Percutaneous valvuloplasty | 6 (0.66%) |
| Previous aortic valve implant | 132 (14.6%) |
| Previous open-heart surgeries | 173 (19.2%) |
| 1 surgery | 154 (17.0%) |
| 2 surgeries | 19 (2.1%) |
| ΔP (mmHg) | |
| Maximum ΔP | 67.0±19.15 |
| Medium ΔP | 41.8±18.8 |
Values are mean±standard deviation or n (%)
AMI=acute myocardial infarction; BMI=body mass index; COPD=chronic obstructive pulmonary disease; ECG=electrocardiogram; Euro-SCORE=European System for Cardiac Operative Risk Evaluation; LVEF=left ventricular ejection fraction; NYHA=New York Heart Association; PCI=percutaneous coronary intervention